2019year11month28day，Asia Pacific Appraisal as the property appraiser represented Kanglong Chemical (Beijing) New Pharmaceutical Technology Co., Ltd. (Shenzhen stock code:300759，Hong Kong stock code:3759）The amount in Hong Kong is aboutHK$4.6billion (approximately5.88Billion dollars)HShares issued globally.

The Asia-Pacific assessment helped the company to surpass the market value10For the property evaluation and update of RMB 100 million, an assessment report that complies with the requirements for property assessment in Chapter 5 of the Listing Rules of the Stock Exchange is issued.

The third largest pharmaceutical market in the worldCROThe company (Drug Discovery Link), Kanglong Chemical is headquartered in Beijing and provides services to Chinese and overseas pharmaceutical companies. Kanglong Chemical is in a leading position in new drug development, preclinical and early clinical development, and has also been expanding downstream capabilities to late clinical development and commercial production.

The joint sponsors of the initial public offering are Goldman Sachs (Asia) Co., Ltd., CITIC Lyon Securities Capital Market Co., Ltd. and Orient Capital (Hong Kong) Limited.

The funds raised by Kanglong Chemical in Hong Kong stocks will be mainly used to expand the capacity and capacity of Chinese laboratories and production facilities, further expansion of foreign business, establishment of a pharmaceutical R&D service platform for research and development of biological agents, expansion of clinical development service strength and capabilities, acquisition Global othersCROCompany and supplementary working capital.